Investigation of Potential Action on Behalf of Current Rafael Holdings Inc. (NYSE: RFL) Shareholders
Rafael Holdings Inc. (“Rafael Holdings”) owns majority interests in two privately held pre-clinical and clinical-stage pharmaceutical companies-Rafael Pharmaceuticals Inc. (“Rafael Pharmaceuticals”) and LipoMedix Pharmaceuticals Ltd., and owns commercial real estate assets.
On June 17, 2021, Rafael Holdings entered into a merger agreement to acquire the remaining equity of Rafael Pharmaceuticals it does not already own in an all-stock transaction. Kessler Topaz Meltzer & Check, LLP is investigating whether the merger is unfair to shareholders of Rafael Holdings, as the chairman of Rafael Holdings and certain members of the board of directors appear to have conflicts of interest in the merger.
If you currently own shares of Rafael Holdings Inc. (NYSE: RFL) and would like to learn more about our investigation, please fill out our online form or contact James Maro at (484) 270-1453; or toll free at (844)-887-9500; or via email at info@ktmc.com.